PURPOSE: To evaluate how optical coherence tomography (OCT) angiography depicts clinical fundus findings in patients with diabetic retinopathy (DR). DESIGN: Prospective study evaluating imaging technology. METHODS: Forty-seven eyes of 25 patients with DR were scanned using a high-speed 840-nm-wavelength spectral-domain optical coherence tomography instrument (RTVue XR Avanti; Optovue, Inc, Fremont, California, USA). Blood flow was detected using the split-spectrum amplitude-decorrelation angiography algorithm. Fluorescein angiography (FA) images were also obtained in all eyes and the ability to visualize microaneurysms, retinal nonperfused areas, and neovascularization was compared with that of the en face OCT angiograms. RESULTS: In 42 eyes, microaneurysms detected by FA near the macula appeared as focally dilated saccular or fusiform capillaries on OCT angiograms of the superficial and/or deep capillary plexus. Retinal nonperfused areas visualized by FA appeared as lesions with no or sparse capillaries on OCT angiograms. Area measurement of retinal nonperfusion near the macula in 7 eyes revealed a difference between the extent of nonperfused areas in superficial and deep plexuses. In 4 eyes, the vascular structures of neovascularization at the optic disc were clearly visualized on OCT angiograms. Decreases and re-increases of flow in new vessels were quantified in an eye treated with anti-vascular endothelial growth factor. CONCLUSIONS: OCT angiography can clearly visualize microaneurysms and retinal nonperfused areas and enables closer observation of each layer of the retinal capillaries. Quantitative information on new vessels can also be obtained. OCT angiography may be clinically useful to evaluate the microvascular status and therapeutic effect of treatments for DR.
PURPOSE: To evaluate how optical coherence tomography (OCT) angiography depicts clinical fundus findings in patients with diabetic retinopathy (DR). DESIGN: Prospective study evaluating imaging technology. METHODS: Forty-seven eyes of 25 patients with DR were scanned using a high-speed 840-nm-wavelength spectral-domain optical coherence tomography instrument (RTVue XR Avanti; Optovue, Inc, Fremont, California, USA). Blood flow was detected using the split-spectrum amplitude-decorrelation angiography algorithm. Fluorescein angiography (FA) images were also obtained in all eyes and the ability to visualize microaneurysms, retinal nonperfused areas, and neovascularization was compared with that of the en face OCT angiograms. RESULTS: In 42 eyes, microaneurysms detected by FA near the macula appeared as focally dilated saccular or fusiform capillaries on OCT angiograms of the superficial and/or deep capillary plexus. Retinal nonperfused areas visualized by FA appeared as lesions with no or sparse capillaries on OCT angiograms. Area measurement of retinal nonperfusion near the macula in 7 eyes revealed a difference between the extent of nonperfused areas in superficial and deep plexuses. In 4 eyes, the vascular structures of neovascularization at the optic disc were clearly visualized on OCT angiograms. Decreases and re-increases of flow in new vessels were quantified in an eye treated with anti-vascular endothelial growth factor. CONCLUSIONS: OCT angiography can clearly visualize microaneurysms and retinal nonperfused areas and enables closer observation of each layer of the retinal capillaries. Quantitative information on new vessels can also be obtained. OCT angiography may be clinically useful to evaluate the microvascular status and therapeutic effect of treatments for DR.
Authors: P P Fang; M Lindner; J S Steinberg; P L Müller; M Gliem; P Charbel Issa; T U Krohne; F G Holz Journal: Ophthalmologe Date: 2016-01 Impact factor: 1.059
Authors: Miao Zhang; Jie Wang; Alex D Pechauer; Thomas S Hwang; Simon S Gao; Liang Liu; Li Liu; Steven T Bailey; David J Wilson; David Huang; Yali Jia Journal: Biomed Opt Express Date: 2015-11-02 Impact factor: 3.732
Authors: Giselle Lynch; Jorge S Andrade Romo; Rachel Linderman; Brian D Krawitz; Shelley Mo; Amir Zakik; Joseph Carroll; Richard B Rosen; Toco Y P Chui Journal: Biomed Opt Express Date: 2018-11-05 Impact factor: 3.732
Authors: Francesco Pichi; Scott D Smith; Emad B Abboud; Piergiorgio Neri; Elizabeth Woodstock; Steven Hay; Emily Levine; Caroline R Baumal Journal: Graefes Arch Clin Exp Ophthalmol Date: 2020-05-30 Impact factor: 3.117
Authors: Michael J Heiferman; Safa Rahmani; Lee M Jampol; Peter L Nesper; Dimitra Skondra; Leo A Kim; Amani A Fawzi Journal: Retina Date: 2017-11 Impact factor: 4.256
Authors: S Tammy Hsu; Hoan T Ngo; Sandra S Stinnett; Nathan L Cheung; Robert J House; Michael P Kelly; Xi Chen; Laura B Enyedi; S Grace Prakalapakorn; Miguel A Materin; Mays A El-Dairi; Glenn J Jaffe; Sharon F Freedman; Cynthia A Toth; Lejla Vajzovic Journal: Ophthalmology Date: 2019-07-15 Impact factor: 12.079
Authors: Christopher S Chung; Peter L Nesper; Justin J Park; Amani A Fawzi Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2018-11-01 Impact factor: 1.300